Plasma rich in growth factors for severe dry eye disease
Part of Eyes & vision clinical trials.
This study tests a treatment made from your own blood (called PRGF) to see if it helps people with severe dry eye disease. The treatment uses growth factors from your blood to help heal and lubricate your eyes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with severe dry eye disease.
- Your doctor has prescribed a treatment called PRGF (platelet-rich growth factors) for your dry eyes.
- You do not have a bleeding or blood clotting disorder.
- You do not have an active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an injection of a special concentrate from your own blood (platelet-rich plasma, or PRP) can help calm severe dry eye disease. It’s meant for people whose dry eye has not improved with other treatments.
This study tests whether eye drops made from your own blood serum (with a natural lubricant) can relieve moderate-to-severe dry eye better than a standard salt solution. If you have dry eye from certain immune conditions or nerve damage, this may help find a more effective treatment.
This study tests whether a new eye drop (rhPRG4) can safely reduce dry eye symptoms caused by graft-versus-host disease (GVHD). It compares the active drops to an inactive placebo to see if they provide better relief.
This study tests a new eye drop treatment made from your own blood serum for severe dry eye that hasn't improved with standard treatments. Researchers will analyze proteins in your tears to understand why this treatment works and who benefits most.
This study makes eye drops from your own blood serum (the liquid part of blood) to help heal dry or damaged corneas. The serum is collected in a special closed system, then used as drops to soothe and repair the eye surface.
This trial tests a new eye drop made from a natural protein (rhPRG4) to see if it safely and effectively relieves dry eye symptoms in people with Sjögren's syndrome. You'll be randomly assigned to receive the study drop or a placebo (inactive) drop for several weeks.
Hear when a new Dry Eye Disease With Severe Keratitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.